High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer
Clinical trial NCT01646034 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01646034
- Sponsor
- The Netherlands Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2023-01-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.